Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02055391 · ClinicalTrials.gov registry record · NA

A Weight Loss Trial for Emotional Eating

A NA study of Obesity, sponsored by Temple University.

Completed
Registry status
NA
Development phase
79
Enrollment target
1
Study location

NCT02055391: Completed NA study of Obesity, sponsored by Temple University.

NCT02055391 is a NA study of Obesity that has completed, run by Temple University. The registered enrollment target is 79 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02055391, a NA study of Obesity, has completed, sponsored by Temple University.

COMPLETED
Registry status
NA
Development phase
79 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether a new weight loss treatment which incorporates behavioral weight loss skills and skills for learning how to identify, manage, and cope with emotions helps with weight loss and emotional eating in people who are overweight and eat in response to emotions.

Conditions Studied

Interventions

  • BEHAVIORAL Behavioral Weight Loss
  • BEHAVIORAL Enhanced Behavioral Weight Loss

Study Locations (1)

Pennsylvania

  • CORE - Philadelphia

Trial Details

FieldValue
Enrollment Target 79 participants
Start Date 2009-09
Est. Completion 2011-02
Phase NA
Temple University

163 total trials

What the finished NCT02055391 record still lists

NCT02055391 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 79 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Behavioral Weight Loss is the first listed.

NCT02055391 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02055391 about?

NCT02055391 is a clinical study titled "A Weight Loss Trial for Emotional Eating". The purpose of this study is to determine whether a new weight loss treatment which incorporates behavioral weight loss skills and skills for learning how to identify, manage, and cope with emotions helps with weight loss and emotional eating in people who are overweight and eat in response to emoti...

What is the current status of trial NCT02055391?

This trial is currently completed. It is a NA study. The enrollment target is 79 participants. The study started on 2009-09. Estimated completion is 2011-02.

What conditions does trial NCT02055391 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT02055391?

The interventions under investigation include: Behavioral Weight Loss (BEHAVIORAL), Enhanced Behavioral Weight Loss (BEHAVIORAL).

Who is sponsoring clinical trial NCT02055391?

This trial is sponsored by Temple University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02055391 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02055391's enrollment target sits among peer trials

79 557th of 1053 higher than 494 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05798897 · 79 participants · Phase 1

    Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • NCT06042439 · 79 participants · NA

    AM vs PM Exercise Training

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02055391, the US trial registry maintained by the National Library of Medicine. NCT02055391 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.